...
机译:Daclatasvir Plus Asunaprevir Plus Beclabuvir +/-利巴韦林用于慢性HCV基因型1感染治疗野生患者
Univ Colorado Denver 1635 Aurora Court B-154 Aurora CO 80045 USA;
Bristol Myers Squibb Co Princeton NJ USA;
Mercy Med Ctr Baltimore MD USA;
Univ Texas Hlth Sci Ctr San Antonio Texas Liver Inst San Antonio TX 78229 USA;
Southern Calif GI &
Liver Ctr Coronado CA USA;
Fdn Invest San Juan PR USA;
Precis Res Inst San Diego CA USA;
Southwest CARE Ctr Santa Fe NM USA;
Res &
Educ Inc Dean Fdn Hlth Madison WI USA;
Orlando Immunol Ctr Orlando FL USA;
Univ Pittsburgh Med Ctr Thomas Starzl Transplant Inst Pittsburgh PA USA;
Miami Res Associates South Miami FL USA;
Inova Fairfax Hosp Ctr Liver Dis Falls Church VA USA;
PRA Hlth Sci Raleigh NC USA;
Atlanta Gastroenterol Associates Liver Ctr Atlanta GA USA;
Bristol Myers Squibb Co Princeton NJ USA;
Bristol Myers Squibb Co Princeton NJ USA;
Bristol Myers Squibb Co 5 Res Pkwy Wallingford CT 06492 USA;
Bristol Myers Squibb Co Princeton NJ USA;
Bristol Myers Squibb Co Princeton NJ USA;
direct-acting antiviral; drug combination; liver disease; therapy;
机译:Daclatasvir Plus Asunaprevir Plus Beclabuvir +/-利巴韦林用于慢性HCV基因型1感染治疗野生患者
机译:达卡他韦和Asunaprevir在非日本亚裔慢性HCV基因1b型感染的患者中,无论是否接受或不接受利巴韦林的干扰素-阿尔法治疗均不合格:3期SVR12中期结果
机译:有效的病毒抑制和α-胎儿蛋白的改善以及日本患者纤维化测量,接受Daclatasvir / Asunaprevir / Beclabuvir固定剂量组合治疗HCV基因型-1感染
机译:HCV / HIV的患者在用Peginterferon Alfa-2a(Pegasys)加上利巴韦林(Copegegs)后HCV治疗后实现持续的病毒学反应,具有改善的健康相关的生活质量
机译:利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
机译:Daclatasvir加上Asunaprevir治疗日本的真实世界HCV基因型1感染患者
机译:达卡他韦,阿舒那普韦和BMS-791325的无干扰素和利巴韦林治疗方案在HCV基因型1感染初治患者中的功效